Urine L-FABP and the urine AN-3199 biological activity albumin excretion rate are plotted in Figure 1. The levels of serum L-FABP (76932-56-4 web Pearson correlation: 20.310, P,.0.001) and urine L-FABP (Pearson correlation: 20.276, P = 0.001), and the urine albumin excretion rate (Pearson correlation: 20.333, P,0.001), were significantly correlated with the eGFR. The correlations between eGFR and serum/urine L-FABP were not significant. The results of correlation analysis for the correlations between baseline eGFR and the baseline levels of serum NGAL, serum LFABP, urine NGAL, and urine L-FABP, and the urine albumin excretion rate are summarized in 1531364 Table 4 and 5. The baseline urine albumin excretion rate and serum L-FABP level were significantly correlated with baseline eGFR by multiple regression analysis (P,0.05). The correlations between baseline eGFR and serum NGAL, urine NGAL and urine L-FABP levels were not significant (Table 4). Due to the distribution of baseline levels of serum NGAL, serum L-FABP, urine NGAL, and urine L-FABP and the urine albumin excretion rate were not normal by Shapiro-Wilk W test (P.0.05), Spearman’s rank correlation coefficient was calculated. The results showed that baseline urine albumin excretion rate, urine NGAL, and serum/urine L-FABP levels were significantly correlated with baseline eGFR (P,0.05) (Table 5).DiscussionDiabetic nephropathy is currently the leading cause of CKD. It is also one of the most significant long-term complications in terms of morbidity and mortality for individual patients with diabetes [25]. It is well known that severe tubulointerstitial damage is associated with a faster decline in eGFR in CKD patients [26]. In this study, we used two renal tubular injury biomarkers, NGAL and L-FABP, in addition to albuminuria, to predict the GFR decline rate in type 2 diabetic patients. Our results showed that the serum L-FABP level was significantly associated with eGFR, using regression analysis in the cross-sectional study. However, only thePredicting GFR Decline in Type 2 DM PatientsFigure 2. Pearson correlation between the rate of eGFR decline and the baseline levels of serum NGAL, serum L-FABP, urine NGAL, and urine L-FABP, and the urine albumin excretion rate. doi:10.1371/journal.pone.0054863.gurine albumin excretion rate was significantly associated with eGFR and the eGFR decline rate in type 2 diabetic patients. Tubulointerstitial and glomerular injuries have important roles in the pathogenesis of diabetic nephropathy [2]. Several recent studies demonstrated that urinary tubular damage markers, such as KIM-1, NGAL and L-FABP, may have the potential to beclinical markers for identifying the development or progression of diabetic nephropathy [27?0]. It was also reported that urine NGAL was significantly elevated in type 1 diabetic patients with or without albuminuria, and that urine NGAL increased significantly with increasing albuminuria [27]. However, some 1317923 studies have shown conflicting results. A study with type 2 diabetic patientsPredicting GFR Decline in Type 2 DM PatientsTable 6. Correlation between the rate of eGFR decline and the baseline levels of serum NGAL, serum L-FABP, urine NGAL, and urine L-FABP, and the urine albumin excretion rate.Table 7. Correlation between the rate of eGFR decline and the baseline levels of serum NGAL, serum L-FABP, urine NGAL, and urine L-FABP, and the urine albumin excretion rate.Rate of eGFR decline Urine albumin Serum NGAL Serum L-FABP Urine NGAL Urine L-FABPStandardized coefficients.Urine L-FABP and the urine albumin excretion rate are plotted in Figure 1. The levels of serum L-FABP (Pearson correlation: 20.310, P,.0.001) and urine L-FABP (Pearson correlation: 20.276, P = 0.001), and the urine albumin excretion rate (Pearson correlation: 20.333, P,0.001), were significantly correlated with the eGFR. The correlations between eGFR and serum/urine L-FABP were not significant. The results of correlation analysis for the correlations between baseline eGFR and the baseline levels of serum NGAL, serum LFABP, urine NGAL, and urine L-FABP, and the urine albumin excretion rate are summarized in 1531364 Table 4 and 5. The baseline urine albumin excretion rate and serum L-FABP level were significantly correlated with baseline eGFR by multiple regression analysis (P,0.05). The correlations between baseline eGFR and serum NGAL, urine NGAL and urine L-FABP levels were not significant (Table 4). Due to the distribution of baseline levels of serum NGAL, serum L-FABP, urine NGAL, and urine L-FABP and the urine albumin excretion rate were not normal by Shapiro-Wilk W test (P.0.05), Spearman’s rank correlation coefficient was calculated. The results showed that baseline urine albumin excretion rate, urine NGAL, and serum/urine L-FABP levels were significantly correlated with baseline eGFR (P,0.05) (Table 5).DiscussionDiabetic nephropathy is currently the leading cause of CKD. It is also one of the most significant long-term complications in terms of morbidity and mortality for individual patients with diabetes [25]. It is well known that severe tubulointerstitial damage is associated with a faster decline in eGFR in CKD patients [26]. In this study, we used two renal tubular injury biomarkers, NGAL and L-FABP, in addition to albuminuria, to predict the GFR decline rate in type 2 diabetic patients. Our results showed that the serum L-FABP level was significantly associated with eGFR, using regression analysis in the cross-sectional study. However, only thePredicting GFR Decline in Type 2 DM PatientsFigure 2. Pearson correlation between the rate of eGFR decline and the baseline levels of serum NGAL, serum L-FABP, urine NGAL, and urine L-FABP, and the urine albumin excretion rate. doi:10.1371/journal.pone.0054863.gurine albumin excretion rate was significantly associated with eGFR and the eGFR decline rate in type 2 diabetic patients. Tubulointerstitial and glomerular injuries have important roles in the pathogenesis of diabetic nephropathy [2]. Several recent studies demonstrated that urinary tubular damage markers, such as KIM-1, NGAL and L-FABP, may have the potential to beclinical markers for identifying the development or progression of diabetic nephropathy [27?0]. It was also reported that urine NGAL was significantly elevated in type 1 diabetic patients with or without albuminuria, and that urine NGAL increased significantly with increasing albuminuria [27]. However, some 1317923 studies have shown conflicting results. A study with type 2 diabetic patientsPredicting GFR Decline in Type 2 DM PatientsTable 6. Correlation between the rate of eGFR decline and the baseline levels of serum NGAL, serum L-FABP, urine NGAL, and urine L-FABP, and the urine albumin excretion rate.Table 7. Correlation between the rate of eGFR decline and the baseline levels of serum NGAL, serum L-FABP, urine NGAL, and urine L-FABP, and the urine albumin excretion rate.Rate of eGFR decline Urine albumin Serum NGAL Serum L-FABP Urine NGAL Urine L-FABPStandardized coefficients.
Related Posts
F all somatic mutations were not detectable across every tumor region
F all somatic mutations were not detectable across every tumor region [10]. The major practical conclusion of this research was that (p. 883) intratumor heterogeneity can lead to underestimation of the tumor genomics landscape portrayed from single tumor-biopsy samples and may present major challenges to personalized-medicine and biomarker development [10]. To be more precise, the […]
Letal 142880-36-2 Autophagy muscle cells. Bischoff et al. (7) demonstrated intramyonuclear staining for the VDR
Letal 142880-36-2 Autophagy muscle cells. Bischoff et al. (7) demonstrated intramyonuclear staining for the VDR working with VDR antibody 97A (Affinity BioReagents) in frozen cross sections of human skeletal muscle mass by means of immunohistochemistry. But the isolation with the VDR in skeletal muscle tissue hasn’t been dependable throughout all scientific tests. A current report […]
S' heels of senescent cells, Y. Zhu et al.(A) (B)(C)(D)(E)(F)(G)(H)(I)Fig. 3 Dasatinib and quercetin reduce
S’ heels of senescent cells, Y. Zhu et al.(A) (B)(C)(D)(E)(F)(G)(H)(I)Fig. 3 Dasatinib and quercetin reduce senescent cell abundance in mice. (A) Effect of D (250 nM), Q (50 lM), or D+Q on levels of senescent Ercc1-deficient murine embryonic fibroblasts (MEFs). Cells were exposed to drugs for 48 h prior to analysis of SA-bGal+ cells using […]